The Mosaic Company (NYSE: MOS) has reported E.P.S. of $-0.01 for its third fiscal quarter (ending September 30) versus $2.45 for the same period a year ago — a decline of -100%. This performance was […]
Air Products and Chemicals Inc. (NYSE: APD) has reported earnings for its fourth fiscal quarter (ending September 30) of $3.08 versus $2.57 for the same period a year ago — an increase of 20%. However, […]
The Hain Celestial Group Inc (NASDAQ: HAIN) has reported a loss for its first fiscal quarter (ending September 30) of $-0.12 versus $0.08 for the same period a year ago — a decline of -250%. […]
The GEO Group Inc (NYSE: GEO) has reported E.P.S. of $0.17 for its third fiscal quarter (ending September 30) versus $0.26 for the same period a year ago — a decline of -35%. This result […]
Civitas Resources Inc (NYSE: CIVI) has reported earnings for its third fiscal quarter (ending September 30) of $1.57 versus $4.77 for the same period a year ago — a decline of -67%. This performance was […]
EVERGY INC (NASDAQ: EVRG) has reported E.P.S. of $1.53 for its third fiscal quarter (ending September 30) versus $1.86 for the same period a year ago — a decline of -18%. This performance was $-0.31 […]
HCI Group Inc (NYSE: HCI) has reported E.P.S. of $1.53 for its third fiscal quarter (ending September 30) versus $-5.66 for the same period a year ago. Relative to the consensus estimate of $0.31, this […]
For its third fiscal quarter (ending September 30), Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported a -15% decline in E.P.S. from $0.92 a year ago to $0.78 in the current quarter. This performance was […]
Primoris Services Corp (NYSE: PRIM) has reported earnings for its third fiscal quarter (ending September 30) of $0.90 versus $0.81 for the same period a year ago — an increase of 11%. This performance was […]
For its third fiscal quarter (ending September 30), Sage Therapeutics Inc (NASDAQ: SAGE) has reported E.P.S. of $-3.37 compared to $-2.31 a year ago. Relative to the consensus estimate of $-2.69, this was a shortfall […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research